Development of Monoclonal Antibodies to Types C, D, F and G Botulinum Toxins
$475,670Y01FY2012AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
Clostridium botulinum neurotoxins are known to be among the most potent and dangerous biological agents, because exposure to them can cause a life threatening paralytic disease syndrome. This IAA will support the development of monoclonal antibodies for neutralization of botulinum neurotoxin serotypes C, D, F and G, as well as support in vivo studies to characterize the potency of these antibodies.
View original record on NIH RePORTER →